Exploring the pharmacological mechanism of Glycyrrhiza uralensis against KOA through integrating network pharmacology and experimental assessment
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Jianbo Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Orthopedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chin…. Hauptthemen laut MEDLINE: Glycyrrhiza uralensis, Molecular Docking Simulation, Osteoarthritis, Knee, Network Pharmacology. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, the Research Project of Zhejiang Chinese Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Knee osteoarthritis (KOA), a major health and economic problem facing older adults worldwide, is a degenerative joint disease. Glycyrrhiza uralensis Fisch. (GC) plays an integral role in many classic Chinese medicine prescriptions for treating knee osteoarthritis. Still, the role of GC in treating KOA is unclear. To explore the pharmacological mechanism of GC against KOA, UPLC‐Q‐TOF/MS was conducted to detect the main compounds in GC. The therapeutic effect of GC on DMM‐induced osteoarthritic mice was assessed by histomorphology, μCT, behavioural tests, and immunohistochemical staining. Network pharmacology and molecular docking were used to predict the potential targets of GC against KOA. The predicted results were verified by immunohistochemical staining Animal experiments showed that GC had a protective effect on DMM‐induced KOA, mainly in the improvement of movement disorders, subchondral bone sclerosis and cartilage damage. A variety of flavonoids and triterpenoids were detected in GC via UPLC‐Q‐TOF/MS, such as Naringenin. Seven core targets (JUN, MAPK3, MAPK1, AKT1, TP53, RELA and STAT3) and three main pathways (IL‐17, NF‐κB and TNF signalling pathways) were discovered through network pharmacology analysis that closely related to inflammatory response. Interestingly, molecular docking results showed that the active ingredient Naringenin had a good binding effect on anti‐inflammatory‐related proteins. In the verification experiment, after the intervention of GC, the expression levels of pp65 and F4/80 inflammatory indicators in the knee joint of KOA model mice were significantly downregulated. GC could improve the inflammatory environment in DMM‐induced osteoarthritic mice thus alleviating the physiological structure and dysfunction of the knee joint. GC might play an important role in the treatment of knee osteoarthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Orthopedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
- College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
- The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Orthopedic Joint Surgery, Hangzhou Fuyang Hospital of TCM Orthopaedics and Traumatology, Hangzhou, China.
- Department of the Orthopedics of TCM, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Hangzhou Yiyuan Pharmaceutical Technology Co., Ltd., Hangzhou, China.
ORCID-Profile: Jianbo Xu, Pinger Wang
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- the Research Project of Zhejiang Chinese Medical University
- National Natural Science Foundation of China
- the State Administration of Traditional Chinese Medicine of Zhejiang Province
- Zhejiang Provincial Natural Science Fundfor Distinguished Young Scholar of China
Zitieren
APA
Xu, J., Sun, Q., Qiu, M., Wu, Y., Cheng, L., Jiang, N., Zhang, R., Chen, J., Yuan, W., Jin, H., Wang, W., Cai, Y., Zhang, C., & Wang, P. (2024). Exploring the pharmacological mechanism of Glycyrrhiza uralensis against KOA through integrating network pharmacology and experimental assessment. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18319
Vancouver
Xu J, Sun Q, Qiu M, Wu Y, Cheng L, Jiang N, et al. Exploring the pharmacological mechanism of Glycyrrhiza uralensis against KOA through integrating network pharmacology and experimental assessment. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18319
BibTeX
@article{Xu2024,
author = {Xu, Jianbo and Sun, Qi and Qiu, Min and Wu, Yungang and Cheng, Liangyan and Jiang, Nanwan and Zhang, Ruogu and Chen, Jiali and Yuan, Wenhua and Jin, Hongting and Wang, Weidong and Cai, Yunhuo and Zhang, Chunchun and Wang, Pinger},
title = {Exploring the pharmacological mechanism of Glycyrrhiza uralensis against KOA through integrating network pharmacology and experimental assessment},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18319}
}
EUVIMED